Neoral
- Product NDC
- 0078-0248
- 11-digit product format
- 000780248
- Labeler code
- 0078
- Product ID
- 0078-0248_df11902a-3b90-428d-80f5-d587be982b4c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cyclosporine
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA050715
- Marketing category
- NDA
- Marketing start
- 1995-07-14
- Substance
- CYCLOSPORINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Neoral
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYCLOSPORINE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 83HN0GTJ6D |
| Rxcui | 241834, 835886, 835894, 835899, 835909, 835911 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0078-0248-15 | Neoral | 30 in 1 CARTON | CAPSULE, LIQUID FILLED | 30 | | 28 |
| 0078-0248-61 | Neoral | 1 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 1 | | 28 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CYCLOSPORINE | ACTIVE INGREDIENT | 83HN0GTJ6D | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| CYCLOSPORINE | ACTIVE MOIETY | 83HN0GTJ6D | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| COCHINEAL | INACTIVE INGREDIENT | TZ8Z31B35M | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| CORN OIL | INACTIVE INGREDIENT | 8470G57WFM | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| POLYOXYL 40 HYDROGENATED CASTOR OIL | INACTIVE INGREDIENT | 7YC686GQ8F | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 15 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0078-0248 | NEORAL (CYCLOSPORINE) CAPSULE, LIQUID FILLED NEORAL (CYCLOSPORINE) SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 26 | Current NDC, Legacy NDC, 2 package rows | 20240719_94461af3-11f1-4670-95d4-2965b9538ae3.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 241834 | cycloSPORINE, modified 100 MG Oral Capsule | PSN | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835886 | cycloSPORINE, modified 100 MG/mL Oral Solution | PSN | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835894 | cycloSPORINE, modified 25 MG Oral Capsule | PSN | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835899 | NEORAL 100 MG in 1 mL Oral Solution | PSN | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835911 | Neoral 100 MG Oral Capsule | PSN | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835909 | Neoral 25 MG Oral Capsule | PSN | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835911 | cyclosporine, modified 100 MG Oral Capsule [Neoral] | SBD | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835899 | cyclosporine, modified 100 MG/ML Oral Solution [Neoral] | SBD | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835909 | cyclosporine, modified 25 MG Oral Capsule [Neoral] | SBD | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 241834 | cyclosporine, modified 100 MG Oral Capsule | SCD | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835886 | cyclosporine, modified 100 MG/ML Oral Solution | SCD | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835894 | cyclosporine, modified 25 MG Oral Capsule | SCD | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835911 | Neoral 100 MG Oral Capsule | SY | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835899 | Neoral 100 MG per 1 ML Oral Solution | SY | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
| 835909 | Neoral 25 MG Oral Capsule | SY | 94461af3-11f1-4670-95d4-2965b9538ae3 | 28 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0248-15 | 00078024815 | 30 BLISTER PACK in 1 CARTON (0078-0248-15) / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0248-61) | 30 blister pack | 1995-07-14 | 0000-00-00 | No | No | Current |
| 0078-0248-61 | 00078024861 | 1 in 1 BLISTER PACK | | | | | | Historical |